E
ESLA
Estrella Immunopharma
0.7137
-0.0064-0.89%After Hours: 0.7137 0.0000 0.00%16:04 07/31 EDT
OPEN/PREV CLOSE0.7690/0.7470
TODAY RANGE0.7100-0.7750
VOL13.93K
MARKET CAP32.10M
52 WEEK RANGE0.6781-3.150
AVG VOL (3M)40.12K
% TURNOVER0.03%
TURNOVER0
P/E (TTM)-2.1112
% RANGE8.70%
EPS(TTM)-0.3533
P/E(FORWARD)-2.1311
P/B-6.0397
BVPS-0.1235
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP12.65M
SHARES OUTSTANDING43.03M
NEXT EARNINGS08/10-08/14
FREE FLOAT16.95M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·07/29 12:10
Estrella Immunopharma activates second clinical site for STARLIGHT-1 trial
TipRanks·07/24 12:05
Estrella announces first patient dosed in STARLIGHT-1 Phase I/II trial
Benzinga·07/17 17:05
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga·07/07 12:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
TipRanks·06/30 21:54
Estrella Immunopharma Shareholders Ratify 2026 Auditor Appointment
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.